Aclaris Therapeutics Inc (NASDAQ:ACRS)
| 18.78 Delayed Data As of 4:14pm ET |  +0.71 / +3.93%Today’s Change | 2.43 Today|||52-Week Range 30.38 | +190.26% Year-to-Date |
Latest ACRS News | Press Releases
No recent news for Aclaris Therapeutics Inc.
Today’s Trading
| Previous close | 18.07 |
| Today’s open | 18.01 |
| Day’s range | 17.78 - 19.93 |
| Volume | 35,021 |
| Average volume (3 months) | 632,551 |
| Market cap | $1.1B |
Data as of 4:14pm ET, 09/27/2021
Growth & Valuation
| Earnings growth (last year) | +69.29% |
| Earnings growth (this year) | -28.19% |
| Earnings growth (next 5 years) | +38.60% |
| Revenue growth (last year) | +53.35% |
| P/E ratio | NM |
| Price/Sales | 42.46 |
| Price/Book | 21.63 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INVAInnoviva Inc | +0.93 | +5.75% |
| ENTAEnanta Pharmaceutica... | +1.31 | +2.34% |
| FULCFulcrum Therapeutics... | -0.26 | -0.95% |
| MNKDMannKind Corp | +0.12 | +2.46% |
Data as of 4:14pm ET, 09/27/2021
Financials
| Next reporting date | November 9, 2021 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $6.5M |
| Annual profit (last year) | -$51.0M |
| Net profit margin | -789.17% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Wayne, Pennsylvania |
Forecasts
